Takao Obara

5.3k citations
139 papers · 3.9k indexed · h-index 34
Topics
Parathyroid Disorders and Treatments (36 papers)Thyroid Cancer Diagnosis and Treatment (22 papers)Adrenal and Paraganglionic Tumors (20 papers)

In The Last Decade

Takao Obara

138 papers receiving 3.7k citations

Peers

Takao Obara
Comparison fields: 5 of 108
  • Oncology 1.5k
  • Nephrology 1.3k
  • Endocrinology, Diabetes and Metabolism 1.2k
  • Epidemiology 983
  • Surgery 917
Replace Glen W. Sizemore with:
Glen W. Sizemore United States
Paolo Viacava Italy
Harald Jüppner United States
Wolfgang Saeger Germany
Christine Bellanné‐Chantelot France
Yuji Hiromatsu Japan
Akihiro Yasoda Japan
Adrian Daly Belgium
Stefano Ferrero Italy
Sylvie Salenave France
Takao Obara relative to Glen W. Sizemore United States Glen W. Sizemore's profile →
Citations per field
00.5×8.5×
Glen W. Sizemore · 1×
Citations per year

Countries citing papers authored by Takao Obara

Since Specialization
Citations

This map shows the geographic impact of Takao Obara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takao Obara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takao Obara more than expected).

Fields of papers citing papers by Takao Obara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takao Obara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takao Obara. The network helps show where Takao Obara may publish in the future.

Co-authorship network of co-authors of Takao Obara

This figure shows the co-authorship network connecting the top 25 collaborators of Takao Obara. A scholar is included among the top collaborators of Takao Obara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takao Obara. Takao Obara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 280
2 36
3 0
4 9
5 16
6 39
7 12
8 66
9 10
10 53
11 14
12 51
13 24
14 8
15 1
16 24
17 129
18 1
19 63
20 1

About Takao Obara

Takao Obara is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Oncology, having authored 139 papers that have together received 3.9k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (36 papers), Thyroid Cancer Diagnosis and Treatment (22 papers) and Adrenal and Paraganglionic Tumors (20 papers). The work is most often cited by research in Nephrology (1.3k citations), Endocrinology, Diabetes and Metabolism (1.2k citations) and Oncology (1.5k citations). Takao Obara has collaborated with scholars based in Japan, Pakistan and United States. Frequent co-authors include Yoshihide Fujimoto, Takahiro Okamoto, Masatoshi Iihara, Yukio Ito, Masako Kanbe, Yukio Ito, Takaya Kodama, Kanji Sato, Kazue Takano and Lars‐Ove Farnebo. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026